Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
. These results suggest that PD-L1 on EVs may be another mechanism for glioblastoma to suppress antitumor immunity and support the potential of EVs as biomarkers in tumor patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“EVs derived from a variety of tumor types including melanoma, glioblastoma, breast, and head and neck cancer contain functional PD-L1 on their surface (Chen et al., 2018; Ricklefs et al., 2018; Theodoraki et al., 2018).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Ricklefs et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807
Causal analysis approaches in Ingenuity Pathway Analysis
Krämer, A., Green, J., Pollard, J., & Tugendreich, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt703 · Cited by 5,724
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294 · cited 1×
“One of themost prominent molecules used by tumor cells to engage T cell immune checkpoints is programmed death ligand 1 (PD-L1) (9, 10).”
BackgroundSelf-citationSingle-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063
Cited by
Items 501–600 of 632
Dias, J. O., Fagundes, I. S., Bisio, M. D. C., Barboza, V. D. S., Jacinto, A. A., & Altei, W. F. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189315 · Cited by 4
Nayak, A., & Nishank, S. S. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104927 · Cited by 6
Advances in exosome-related biomarkers for glioblastoma: Basic research and clinical application
Chang, Q., Jiang, Y., Qian, J., Yang, J., Xiao-ling, Y. A. N., & Xue, X. (2018) · Glioma · doi:10.4103/glioma.glioma_35_18 · Cited by 3
Ren, Y., Ge, K., Lü, W., Peng, W., Che, H., Ma, J., Jia, C., & Yao, B. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.133086 · Cited by 3
Extracellular vesicles as biomarkers for AIDS-associated non-Hodgkin lymphoma risk
Martínez, L. E., Magpantay, L. I., Guo, Y., Hegde, P., Detels, R., Hussain, S. K., & Epeldegui, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1259007 · Cited by 3
“PD-L1-expressing EVs can inhibit T-cells found in draining lymph nodes and/or at sites distant from the cancer cell origin (67, 68), and can suppress anti-tumor immunity to promote the progression of cancer (41, 43, 45, 69, 70).”
BackgroundGlioblastoma single extracellular vesicle analysis profiles: wading into new oceans of tumor data
Jones, J. C. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz045 · Cited by 4
Morrissey, S. M., Zhang, F., Yang, C., Wang, Z., Hu, X., Fox, M., Ding, C., Zhang, H., Guo, H., Tieri, D. A., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541359 · Cited by 4
Lyukmanova, E. N., Kirichenko, A. V., Medyanik, I. A., Сергеевич, Я. К., Kirpichnikov, M. P., & Bychkov, M. L. (2024) · Biomedicines · doi:10.3390/biomedicines12122834 · Cited by 2
Kałużna, S., Świerczewska, M., Ciesiółka, S., Partyka, M., Nowicki, M. O., & Wojtowicz, K. (2025) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2025.070356 · Cited by 4
“Exosomal PD-L1 has also been detected in various cancers, including melanoma [48], breast cancer [49], glioma [50], stomach cancer [51], and lung cancer [52].”
TIGIT expression dictates the immunosuppressive reprogramming of myeloid cells in glioblastoma
Asad, M., Inocencio, J. F., Mitrasinovic, S., Aoki, M., Baker, C. E., Hormigo, A., Crisman, C., LASALA, P. A., Eskandar, E. N., Guha, C., et al. (2026) · Neuro-Oncology · doi:10.1093/neuonc/noag044 · Cited by 3
Heat up and Destroy: Immunotherapy of “Cold” Tumors Using the Example of Glioblastoma
Nikitina, Y., Kazakova, A., Bogachek, M. V., Leonteva, A. A., Vasileva, N. S., Sergeevichev, D., Vladimirov, S., Richter, V. A., & Nushtaeva, A. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052457 · Cited by 3
Nezamdoust, F. V., Nezhad‐Mokhtari, P., Mirzaahmadi, B., Mazloumi, Z., Kangari, P., & Rahbarghazi, R. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-05011-7 · Cited by 3
Systemic health impact of cancer-associated extracellular vesicles and particles
Wang, G., Lucotti, S., Bojmar, L., Tobias, G. C., Piszczatowski, R. T., Dror, S., Zhang, H., & Lyden, D. C. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00952-w · Cited by 2
“In the brain, the blood–brain barrier (BBB), formed by interactions between endothelial cells, astrocytes and pericytes, allows selective transport of small proteins and nutrients 48 .”
Mechanisms of Therapeutic Resistance and Recent Advances in Glioblastoma Treatment
Achari, E., Ahmady, F., Sharma, A., Schmidt‐Wolf, I. G. H., Maciaczyk, J., Luwor, R. B., & Achuthan, A. A. (2026) · Immunology and Cell Biology · doi:10.1111/imcb.70144 · Cited by 2
Zahran, A. M., Zahran, Z. A. M., & Rayan, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-96975-4 · Cited by 2
Zhan, R., Wang, S., Guo, W., Gao, X., Liu, X., Xu, K., & Tang, B. (2021) · Chemical Communications · doi:10.1039/d1cc06496g · Cited by 2
The Role of Liquid Biopsy in Brain Tumors
Gamblin, A. S., Hsia, T., Batool, S. M., Khanna, S. K., Escobedo, A. K., Ekanayake, E., Balaj, L., & Carter, B. S. (2023) · Current cancer research · doi:10.1007/978-3-031-22903-9_23 · Cited by 2
Self-citationIntercellular Molecular Transfer Mediated by Extracellular Vesicles in Cancer
Adnani, L., & Rak, J. W. (2024) · Results and problems in cell differentiation · doi:10.1007/978-3-031-62036-2_14 · Cited by 4
Morrissey, S. M. (2020) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3495 · Cited by 2
Tumor cell communication through EVs: new challenges and opportunities
Maire, C. L., & Ricklefs, F. L. (2019) · Trillium Extracellular Vesicles · doi:10.47184/tev.2019.01.03 · Cited by 2
Self-citationSzeliski, K., Fekner, Z., Kasiński, D., Rasmus, M., Kowalski, F., Świtońska, M., Sierakowska, K., Drewa, T. A., & Pokrywczyńska, M. (2025) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2025.102828 · Cited by 1
Colangelo, T., Saponaro, A. A., Mazzoccoli, G., Serviddio, G., & Villani, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411826 · Cited by 1
“These GBM-derived EVs contain immunosuppressive molecules such as PD-L1 and TGF-β [110,111], as well as miRNAs (e.g., miR-10a [93], miR-21 [90–92], miR-29a [94], and miR-1246 [95]) that inhibit immune cell activity [92].”
Extracellular vesicles mediate intercellular transfer of PD-L1 and bystander T-cell suppression
Yeware, A. M., Brown, C., Chang, C.-C., Pennati, A., & Galipeau, J. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06208-y · Cited by 1
“EVs are known to carry diverse biological cargo e.g. proteins, RNA, DNA and mediate to local and systemic inter-cellular communication that promotes tumor progression, angiogenesis, and immune escape [17, 18].”
Fu, Z., Kuang, Y., Li, M., Zhou, K., Shi, H., Gu, Y., Wu, X., Zhu, Y., & Liu, J. (2026) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2025.184 · Cited by 1
de Oliveira, G. P., Zimmerman, A. J., Palu, C. C., Tran, V., Bogut, G., Chidester, S., Tigges, J., Vega, R. A., Aïkawa, E., Jones, J. C., et al. (2026) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2026.101610 · Cited by 1
“These findings align with the concept that GBM-derived EVs contribute to intratumoral heterogeneity and treatment evasion by transferring oncogenic and pro-survival cues to neighboring or distant cells (70).”
Tan, J., Wen, T., Liu, J. S., & Ru, X. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01828-0 · Cited by 2
“In addition to effects on antigen presentation and T-cell priming, CSC-enriched populations may limit T-cell persistence and cytotoxicity through cytokine programs and inhibitory checkpoint signals, forming feedback interactions between immune selection and reduced effector function [270–274].”
Extracellular Vesicles as Master Regulators of Immune Modulation in Multiple Myeloma
Pucci, M., Costanzo, E., Marfia, M., Seidita, G., Fontana, S., Corrado, C., & Alessandro, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146276 · Cited by 1
Sun, X., Wang, X., Zhang, S. H., Long, Y., Wang, D., Gou, C., Zhang, W., Deng, C., Liu, C., & Chen, Z. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03081-x · Cited by 1
Chimeric antigen receptor T-cells for glioblastoma: The journey ahead
Joseph, S. K., Hegde, M. G., & Ahmed, N. (2019) · Glioma · doi:10.4103/glioma.glioma_6_19 · Cited by 1
Adipocyte lipolysis and lipid-derived metabolite signaling
Kirsh, C., Harris, A. M., & Simcox, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00007-5 · Cited by 3
Biogenesis and Functions of Extracellular Vesicles
Zou, W., Zhang, K., Lai, M., Jiang, Y., Zhang, Y., & Bai, X. (2024) · Springer eBooks · doi:10.1007/978-981-99-8365-0_2 · Cited by 2
Wolff, A., Krone, P., Maennicke, J., Henne, J., Oehmcke-Hecht, S., Redwanz, C., Bergmann‐Ewert, W., Junghanß, C., Henze, L., & Maletzki, C. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102053 · Cited by 1
“It has already been shown that glioblastoma-derived EVs have PD-L1 on their surface, which inhibits T cell activation via the PD-1/PD-L1 signaling pathway [60].”
BackgroundInvestigating nano-sized tumor-derived extracellular vesicles in enhancing anti-PD-1 immunotherapy
Abouali, H., Przedborski, M., Kohandel, M., & Poudineh, M. (2024) · Nanoscale · doi:10.1039/d4nr00729h · Cited by 1
Biogenesis of extracellular vesicles and their role in cancer
Sharma, S., Singh, A. N., & Rana, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95258-3.00004-7 · Cited by 1
Advances in the management of high-grade glial tumors
Jacobo, J. A., Aristizabal, J., Vallejo, S., Pineda, D., Bobadilla, I., González, A., Wagner-Gutiérrez, N., Montaño, J., & Cardona, A. F. (2024) · Medicina · doi:10.56050/01205498.2372 · Cited by 1
Characterizing PD-L1-Targeting Extracellular Vesicles Produced by Oncolytic Vaccinia Virus Infection
Chen, A. (2020) · uO Research (University of Ottawa) · doi:10.20381/ruor-24410 · Cited by 1
Hsu, V. W., & Li, J. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733785395.793556396 · Cited by 1
Immunosuppressive Extracellular Vesicles in CLL
Zhong, W., & Guo, W. (2022) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-22-0161 · Cited by 1
Extracellular vesicles : mediators of immune modulation in the lung and as therapeutic vehicles
Ullsten-Wahlund, C. (2018) · Figshare · Cited by 1
Research Progress of Related Mechanisms about Treatment of Glioma by Medicine
张, 莹. (2020) · Pharmacy Information · doi:10.12677/pi.2020.92012
Regulation of Anti-Tumor Immunity and Immunotherapy Response In Colorectal Cancer
Zhao, X. (2020) · University of Minnesota Digital Conservancy (University of Minnesota)
Giantini-Larsen, A. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Cheng, Y., Li, S., Hou, Y., Wang, W., Wang, K., Yuan, Y., & Ye, X. (2021) · Research Square · doi:10.21203/rs.3.rs-291935/v2
“reported the immune evasion mediated by PDL1 on GBM-derived sEVs[38].”
BackgroundYang, Q., Chen, M., Gu, J., Niu, K., Zhao, X., Zheng, L., Xu, Z., Yu, Y., Li, F., Meng, L., et al. (2020) · doi:10.21203/rs.3.rs-87252/v1
Wei, Y., & Shi, J. (2021) · Research Square · doi:10.21203/rs.3.rs-960777/v1
Cheng, Y., Li, S., Hou, Y., Wang, W., Wang, K., Yuan, Y., & Ye, X. (2021) · Research Square · doi:10.21203/rs.3.rs-291935/v1
El‐Deiry, W. S., & Zhou, L. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735453137.793558758
Role of Mesenchymal Stem/Stromal Cells in Cancer Development
Castro-Manrreza, M. E., & Martínez, I. (2023) · Interdisciplinary cancer research · doi:10.1007/16833_2022_103
Zhu, M., Chen, C., Foster, N. R., Hartley, C., Mounajjed, T., Salomao, M. A., Fruth, B. F., Beamer, S. E., Kim, Y., Harrington, S. M., et al. (2023) · doi:10.1158/1078-0432.c.6532334.v1
Self-citationRecent Progress of Nanomedicine and Targeted Drug Delivery for Cancer Treatment
Zhang, H. (2023) · MDPI eBooks · doi:10.3390/books978-3-0365-7040-2
Qiu, Z., Zhao, L., Shen, J., Liang, Z., Wu, Q., Yang, K., Min, L., Gimple, R. C., Yang, Q., Bhargava, S., et al. (2023) · doi:10.1158/2159-8290.22541297
Self-citationTherapeutic Potential of Extracellular Vesicles from Different Cell Sources
Wang, X., & Li, Z. (2023) · Wiley eBooks · doi:10.1002/9783527842155.ch3
Li, W., Cui, Q., Ge, T., Wang, S., Wang, D., He, G., & Yu, J. (2024) · medRxiv · doi:10.1101/2024.01.20.24301560
Marqueurs de réponse thérapeutique du mélanome
Nardin, C. (2021) · theses.fr (ABES) · doi:10.70675/3df0a98dz9c72z4558zafaezd0975db0019f · Cited by 1
Metabolic underliers of cancer cell functional states within human glioblastoma
Saurty-Seerunghen, M. S. (2021) · theses.fr (ABES) · doi:10.70675/83c7c36cz7c87z4d4cza42bz4db84ee4ec34
Study of the role of ral gtpases in exosome secretion and metastatic progression
Ghoroghi, S. (2020) · theses.fr (ABES) · doi:10.70675/d16c8712z7cdez4a5bz9129z0e55526605f2
Liquid Biopsy: Novel Progressions and Comparisons
Gupta, L., Klatt, N., Zameer, H., & Surappa, S. (2024) · Berkeley Scientific Journal · doi:10.5070/bs328264296
Role of extracellular vesicles in renal cell carcinoma
Kumar, N., Bohra, D., Rana, R., Rana, D. S., Gupta, A., & SACHDEVA, M. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95258-3.00012-6
López-Bertoni, H., & Laterra, J. (2025) · Qeios · doi:10.32388/70p2ux
Koffler, D. M., Ebner, D. K., Lehrer, E. J., Fekrmandi, F., Ehret, F., Mahmoudi, M., Beltran, C. J., Trifiletti, D. M., Vallow, L. A., Rutenberg, M. S., et al. (2025) · Applied Radiation Oncology · doi:10.37549/aro-d-25-00003p2
Circumventing vascular barriers for effective immunotherapy in brain tumors – focus on glioblastoma
Rak, J. W. (2025) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2025-0012
Overcoming brain cancer treatment resistance: mechanisms and strategies
Mosoane, B., Marutha, T., Nonxuba, M., Sengupta, S., & Dlamini, Z. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-45495-0.00004-8
Kemper, M., Menck, K., & Bleckmann, A. (2025) · Trillium Extracellular Vesicles · doi:10.47184/tev.2025.01.05
The Science of PD-1/PD-L1 Pathway in Gliomas: Far beyond the Obvious
Scheffel, T. B., & Begnini, K. R. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1011981 · Cited by 1
Discovery of novel indoline derivatives as potent small molecule PD-L1 inhibitors
Yang, D. M., Kang, Y. W., Kim, K., Lee, S., Oh, T., Shin, K. J., Kim, M. J., Heo, T., & Kim, I. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130458
Sun, H., Chu, Z., & Liang, Q. (2025) · Small · doi:10.1002/smll.202509696
Regulatory T cells in Colorectal Cancer immune tolerance
Pereira, L. D. N. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/j201-1494
Tankov, S., Petrovic, M., Lecoultre, M., Espinoza, F. I., Harane, N. E., Bes, V., Chliate, S., Bedoya, D. M., Jordan, O., Borchard, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26684343
Tankov, S., Petrovic, M., Lecoultre, M., Espinoza, F. I., Harane, N. E., Bes, V., Chliate, S., Bedoya, D. M., Jordan, O., Borchard, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26684337
Tankov, S., Petrovic, M., Lecoultre, M., Espinoza, F. I., Harane, N. E., Bes, V., Chliate, S., Bedoya, D. M., Jordan, O., Borchard, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26684346
Tankov, S., Petrovic, M., Lecoultre, M., Espinoza, F. I., Harane, N. E., Bes, V., Chliate, S., Bedoya, D. M., Jordan, O., Borchard, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26684340
Zheng, Y., Liu, L., Wang, Y., Xiao, S., Mai, R., Zhu, Z., & Cao, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14355382
Wang, J., Tong, L., Lin, G., Wang, H., Zhang, L., & Yang, X. (2020) · Figshare · doi:10.6084/m9.figshare.13023887
Chen, Q., Jin, J., Huang, X., Wu, F., Hongguang, H., & Zhan, R. (2021) · Figshare · doi:10.6084/m9.figshare.14561277
Zheng, Y., Liu, L., Wang, Y., Xiao, S., Mai, R., Zhu, Z., & Cao, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14355394
Tankov, S., Petrovic, M., Lecoultre, M., Espinoza, F. I., Harane, N. E., Bes, V., Chliate, S., Bedoya, D. M., Jordan, O., Borchard, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26684331
Development of a 3D biomimetic in vitro platform to study EV cargo in rectal cancer radio-response
Ribeiro, M. D. C. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/fh53-t177
Wang, J., Tong, L., Lin, G., Wang, H., Zhang, L., & Yang, X. (2020) · Figshare · doi:10.6084/m9.figshare.13023893
Zheng, Y., Liu, L., Wang, Y., Xiao, S., Mai, R., Zhu, Z., & Cao, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14355391
Zheng, Y., Liu, L., Wang, Y., Xiao, S., Mai, R., Zhu, Z., & Cao, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14355388
Zheng, Y., Liu, L., Wang, Y., Xiao, S., Mai, R., Zhu, Z., & Cao, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14355385
Tankov, S., Petrovic, M., Lecoultre, M., Espinoza, F. I., Harane, N. E., Bes, V., Chliate, S., Bedoya, D. M., Jordan, O., Borchard, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25271929
Tankov, S., Petrovic, M., Lecoultre, M., Espinoza, F. I., Harane, N. E., Bes, V., Chliate, S., Bedoya, D. M., Jordan, O., Borchard, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25271871
Tankov, S., Petrovic, M., Lecoultre, M., Espinoza, F. I., Harane, N. E., Bes, V., Chliate, S., Bedoya, D. M., Jordan, O., Borchard, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26684334
Wang, J., Tong, L., Lin, G., Wang, H., Zhang, L., & Yang, X. (2020) · Figshare · doi:10.6084/m9.figshare.13023890
Tankov, S., Petrovic, M., Lecoultre, M., Espinoza, F. I., Harane, N. E., Bes, V., Chliate, S., Bedoya, D. M., Jordan, O., Borchard, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26684349
The roles of cancer cell-derived extracellular vesicles in the tumor microenvironment
Liu, Y. (2025) · eCommons (Cornell University) · doi:10.7298/k0zm-6z14
Liquid biopsy in pancreatic cancer-Predictive value of extracellular vesicles
Νικολαΐδου, Ε. Ι., & Νικολαΐδου, Ε. Ι. (2025) · University of Thessaly Institutional Repository (University of Thessaly)
Extracellular vesicles as liquid biopsy tools for personalized therapeutic goals in glioblastoma
Menaceur, C., Unnikrishnan, K., Ita, M., Lassen, U., Belting, M., Korshoej, A. R., Bjarkam, C. R., & Chandran, V. I. (2026) · Brain · doi:10.1093/brain/awag003 · Cited by 1
The immune awakening: Transformative strategies against brain tumors
Abdullah, A., Malik, T., Shuja, H., Bashir, M., Wamiq, U., Ibrahim, H. Y., & Aamir, M. S. (2026) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2026.125787
Liu, F., Chen, J., Yu, M., Yanlin, L., Wang, W., Pei, Y., 杨淑艳, & Yu, W. (2026) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdag075
Human Cytomegalovirus as a Therapeutic Target in Glioma Stem Cells
Dargham, T. B., Vaios, E., Lawler, S. E., & Batich, K. A. (2026) · Cells · doi:10.3390/cells15070575
“GSCs also release extracellular vesicles bearing PD-L1, which suppress T-cell-mediated attack [41].”
Self-citationKnowledge Mapping of Exosomes in Glioblastoma: A Bibliometric Analysis From 2006 to 2025
Li, J., Wu, D., Chen, Z., Miao, C., Wang, J., & Luo, Q. (2026) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000012707
Boukredine, A. (2021) · theses.fr (ABES) · doi:10.70675/169b99afz5507z4d66zbbfazaaebacd91737 · Cited by 1
Study of the properties of exosomes modified as therapeutic vehicles in vivo
Corona, M. L. (2024) · theses.fr (ABES) · doi:10.70675/5dd1ae44z81abz492czb55ezc0f973a24fe2
Hétérogénéité et plasticité de l’intégrine α5 dans les cellules souches de glioblastome
Messé, M. (2023) · theses.fr (ABES) · doi:10.70675/5bee424dz19e3z4870zb9b1z927eaa272304
Metadata
- Authors
- Ricklefs, F. L., Alayo, Q., Krenzlin, H., Mahmoud, A. B., Speranza, M. C., Nakashima, H., Hayes, J. L., Lee, K., Balaj, L., Passaro, C., Rooj, A. K., Krasemann, S., Carter, B. S., Chen, C. C., Steed, T., Treiber, J., Rodig, S., Yang, K., Nakano, I., Lee, H., Weissleder, R., Breakefield, X. O., Godlewski, J., Westphal, M., Lamszus, K., Freeman, G. J., Bronisz, A., Lawler, S. E., & Chiocca, E. A.
- Affiliations
- Brigham and Women's Hospital (US)
- University of California, Berkeley (US)
- Massachusetts General Hospital (US)
- University Medical Center Hamburg-Eppendorf (DE)
- University of California San Diego (US)
- Comprehensive Cancer Center, University of Birmingham, Birmingham, AL 35294, USA.
- Harvard University (US)
- Corresponding author
- Lawler, Sean E.
- Chiocca, E. Antonio
- ORCID
- Ricklefs, Franz L.
- Alayo, Quazim
- Krenzlin, Harald
- Mahmoud, Ahmad B.
- Speranza, Maria C.
- Nakashima, Hiroshi
- Hayes, Josie L.
- Lee, Kyungheon
- Balaj, Leonora
- Passaro, Carmela
- Rooj, Arun K.
- Krasemann, Susanne
- Carter, Bob S.
- Chen, Clark C.
- Steed, Tyler
- Treiber, Jeffrey
- Rodig, Scott
- Yang, Katherine
- Nakano, Ichiro
- Lee, Hakho
- Weissleder, Ralph
- Breakefield, Xandra O.
- Godlewski, Jakub
- Westphal, Manfred
- Lamszus, Katrin
- Freeman, Gordon J.
- Bronisz, Agnieszka
- Lawler, Sean E.
- Chiocca, E. Antonio
- Venue
- Science Advances
- Published
- 2018-03-02
- Volume
- 4
- Issue
- 3
- Pages
- eaar2766-eaar2766
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC5842038
- OpenAlex
- W2793992337
- Cited by
- 610
- References
- 42
- Citations by year
- 2026: 48 · 2025: 68 · 2024: 76 · 2023: 76 · 2022: 85 · 2021: 111 · 2020: 75 · 2019: 56 · 2018: 15
- FWCI
- 22.86
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Science Advances (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (CA176203-01A1)
- National Cancer Institute (P01 CA69246)
- Deutsche Forschungsgemeinschaft (RI 2616/1-1, RI 2616/2-1)
- National Institute of Health (NCI P01 CA69246)
- American-Italian Cancer Foundation Post-doctoral Research Fellowship
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Keywords
- glioblastoma, PD-L1, extracellular vesicles, immune evasion, antitumor immunity, tumor microenvironment, biomarkers
- MeSH terms
- Extracellular Vesicles, Antigens, Neoplasm, Brain Neoplasms, Glioblastoma, Humans, Interferon-gamma, Lymphocyte Activation, Receptors, Antigen, T-Cell, T-Lymphocytes, Neoplastic Stem Cells, Up-Regulation, Gene Expression Regulation, Neoplastic, Cell Line, Tumor, Immune Evasion, B7-H1 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.